Skip to main content
FinSpry Logo
FinSpry
CANF logo
CANF
(NYSEAMERICAN)
Can-Fite BioPharma Ltd.
$3.06-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Can-Fite BioPharma (CANF) Stock Price & Financial Analysis

Can-Fite BioPharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.01 - $3.12
52-Week High$36.40
52-Week Low$2.95
Open$3.05
Volume21.37K
Average Volume (3M)19.99K
Market Cap2.80M
Shares Outstanding914.56K
Price to Sales (P/S)62.75
Price to Book (P/B)8.40
EV/EBITDA-3.23
Revenue (TTM)560.00K
Net Income (TTM)-8.80M
Free Cash Flow (TTM)-8.36M
EPS (TTM)$-0.77
Profit Margin-1571.25%
Operating Margin-1595.36%
Return on Equity (ROE)-210.30%
Debt to Equity0.02
50-Day MA$4.09
200-Day MA$9.72
52-Week Change-88.96%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateNov 12, 2013

Frequently Asked Questions About Can-Fite BioPharma

What is the current stock price for CANF?

As of the latest trading session, CANF stock trades at $3.03. The 52-week range is $2.95–$36.40, with a day range of $3.01–$3.12.

What is the P/E ratio for CANF?

The P/E ratio (Price-to-Earnings) for CANF is shown in the Key Statistics section. This valuation metric helps compare Can-Fite BioPharma Ltd. to industry peers.

Does CANF pay dividends?

Can-Fite BioPharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CANF?

Analyst ratings and recommendations for CANF are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CANF?

Can-Fite BioPharma's market capitalization is $2.8M, classifying it as a micro-cap company. Can-Fite BioPharma operates in the Healthcare sector within the Biotechnology industry.